118 related articles for article (PubMed ID: 15056460)
1. Effect of a paraneoplastic cerebellar degeneration-associated neural protein on B-myb promoter activity.
Sakai K; Kitagawa Y; Saiki S; Saiki M; Hirose G
Neurobiol Dis; 2004 Apr; 15(3):529-33. PubMed ID: 15056460
[TBL] [Abstract][Full Text] [Related]
2. Induction of cytotoxic T lymphocytes specific for paraneoplastic cerebellar degeneration-associated antigen in vivo by DNA immunization.
Sakai K; Shirakawa T; Kitagawa Y; Li Y; Hirose G
J Autoimmun; 2001 Dec; 17(4):297-302. PubMed ID: 11771954
[TBL] [Abstract][Full Text] [Related]
3. PKN interacts with a paraneoplastic cerebellar degeneration-associated antigen, which is a potential transcription factor.
Takanaga H; Mukai H; Shibata H; Toshimori M; Ono Y
Exp Cell Res; 1998 Jun; 241(2):363-72. PubMed ID: 9637778
[TBL] [Abstract][Full Text] [Related]
4. [The detection of anti-Purkinje cell antibody (anti-Yo antibody) by ELISA using recombinant Yo fusion protein].
Tanaka K; Tanaka M; Onodera O; Igarashi S; Tsuji S
No To Shinkei; 1994 Jan; 46(1):47-51. PubMed ID: 8136199
[TBL] [Abstract][Full Text] [Related]
5. [A candidate peptide reacting with cytotoxic T cells in paraneoplastic cerebellar degeneration with anti-Yo antibody].
Tanaka M; Tanaka K
Rinsho Shinkeigaku; 1999 Jun; 39(6):603-5. PubMed ID: 10502981
[TBL] [Abstract][Full Text] [Related]
6. Failure to detect cytotoxic T cell activity against recombinant Yo protein using autologous dendritic cells as the target in a patient with paraneoplastic cerebellar degeneration and anti-Yo antibody.
Tanaka M; Tanaka K; Idezuka J; Tsuji S
Exp Neurol; 1998 Apr; 150(2):337-8. PubMed ID: 9527904
[TBL] [Abstract][Full Text] [Related]
7. [Paraneoplastic cerebellar degeneration associated with ovarian cancer: anti-Yo immunoreactivity in autoptic cerebellum and ovarian carcinoma].
Bartos A; Stourac P; Rusina R; Sejdová M; Velenská Z
Nervenarzt; 2002 Oct; 73(10):995-8. PubMed ID: 12376889
[TBL] [Abstract][Full Text] [Related]
8. [Importance of plasmapheresis in the treatment of paraneoplastic cerebellar degeneration].
Basić-Jukić N; Kes P; Basić-Kes V; Brunetta B
Acta Med Croatica; 2004; 58(1):63-6. PubMed ID: 15125396
[TBL] [Abstract][Full Text] [Related]
9. Anti-Yo-associated paraneoplastic cerebellar degeneration in a man with gastric adenocarcinoma.
Meglic B; Graus F; Grad A
J Neurol Sci; 2001 Apr; 185(2):135-8. PubMed ID: 11311295
[TBL] [Abstract][Full Text] [Related]
10. Anti-Yo antibody uptake and interaction with its intracellular target antigen causes Purkinje cell death in rat cerebellar slice cultures: a possible mechanism for paraneoplastic cerebellar degeneration in humans with gynecological or breast cancers.
Greenlee JE; Clawson SA; Hill KE; Wood B; Clardy SL; Tsunoda I; Carlson NG
PLoS One; 2015; 10(4):e0123446. PubMed ID: 25885452
[TBL] [Abstract][Full Text] [Related]
11. Morphological and immunohistochemical characterization of paraneoplastic cerebellar degeneration associated with Yo antibodies.
Storstein A; Krossnes BK; Vedeler CA
Acta Neurol Scand; 2009 Jul; 120(1):64-7. PubMed ID: 19486326
[TBL] [Abstract][Full Text] [Related]
12. [Paraneoplastic cerebellar degeneration--characterization of anti-Yo antibody and underlying cancer].
Tanaka K; Tanaka M; Onodera O; Tsuji S
Rinsho Shinkeigaku; 1995 Jul; 35(7):770-4. PubMed ID: 8777801
[TBL] [Abstract][Full Text] [Related]
13. Interaction of a paraneoplastic cerebellar degeneration-associated neuronal protein with the nuclear helix-loop-helix leucine zipper protein MRG X.
Sakai K; Shirakawa T; Li Y; Kitagawa Y; Hirose G
Mol Cell Neurosci; 2002 Apr; 19(4):477-84. PubMed ID: 11988016
[TBL] [Abstract][Full Text] [Related]
14. Trial to establish an animal model of paraneoplastic cerebellar degeneration with anti-Yo antibody. 2. Passive transfer of murine mononuclear cells activated with recombinant Yo protein to paraneoplastic cerebellar degeneration lymphocytes in severe combined immunodeficiency mice.
Tanaka K; Tanaka M; Igarashi S; Onodera O; Miyatake T; Tsuji S
Clin Neurol Neurosurg; 1995 Feb; 97(1):101-5. PubMed ID: 7788964
[TBL] [Abstract][Full Text] [Related]
15. Targeting an E2F site in the mouse genome prevents promoter silencing in quiescent and post-mitotic cells.
Tavner F; Frampton J; Watson RJ
Oncogene; 2007 Apr; 26(19):2727-35. PubMed ID: 17072340
[TBL] [Abstract][Full Text] [Related]
16. [Paraneoplastic cerebellar degeneration (PCD) with anti-Yo antibodies in ovarian carcinoma].
Holzmann P; Holy D; Stillhard G; Janda M; Möbr P
Schweiz Med Wochenschr; 1998 Jun; 128(23):906-8. PubMed ID: 9658519
[TBL] [Abstract][Full Text] [Related]
17. Induction of humoral responses specific for paraneoplastic cerebellar degeneration-associated antigen by whole recombinant yeast immunization.
Saiki M; Sakai K; Saiki S; Kitagawa Y; Nakanishi M; Hirose G
J Autoimmun; 2005 May; 24(3):203-8. PubMed ID: 15848042
[TBL] [Abstract][Full Text] [Related]
18. Regulation of the cyclin D1 and cyclin A1 promoters by B-Myb is mediated by Sp1 binding sites.
Bartusel T; Schubert S; Klempnauer KH
Gene; 2005 May; 351():171-80. PubMed ID: 15922873
[TBL] [Abstract][Full Text] [Related]
19. Anti-Yo antibody-mediated paraneoplastic cerebellar degeneration in a man with esophageal adenocarcinoma.
Xia K; Saltzman JR; Carr-Locke DL
MedGenMed; 2003 Aug; 5(3):18. PubMed ID: 14600654
[TBL] [Abstract][Full Text] [Related]
20. Co-regulation of B-Myb expression by E2F1 and EGF receptor.
Hanada N; Lo HW; Day CP; Pan Y; Nakajima Y; Hung MC
Mol Carcinog; 2006 Jan; 45(1):10-7. PubMed ID: 16299810
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
